A Comparative Real‐World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Documenti analoghi

• Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data
  di: Joshua U. Okonkwo, et al.
  Pubblicazione: (2025)
• Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy
  di: Yu‐Ri Choi, et al.
  Pubblicazione: (2025)
• Incidence of Diabetic Ketoacidosis in Dapagliflozin‐Treated Japanese Patients With Type 1 Diabetes Mellitus: An Observational Cohort Database Study
  di: Reiko Tamura, et al.
  Pubblicazione: (2025)
• Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study
  di: Ida M. Heerfordt, et al.
  Pubblicazione: (2025)
• Impact of COVID ‐19 Restrictions on Nationwide Antipsychotic Use: Results From the Trends in Drug Utilization During COVID ‐19 Pandemic in Turkey ( PANDUTI ‐ TR ) Study
  di: Caner Vizdiklar, et al.
  Pubblicazione: (2026)